206 related articles for article (PubMed ID: 28349497)
1. Alternative Chk1-independent S/M checkpoint in somatic cells that prevents premature mitotic entry.
Zineldeen DH; Shafik NM; Li SF
Med Oncol; 2017 Apr; 34(4):70. PubMed ID: 28349497
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Chk1 prevents premature mitotic entry.
Matsuyama M; Goto H; Kasahara K; Kawakami Y; Nakanishi M; Kiyono T; Goshima N; Inagaki M
J Cell Sci; 2011 Jul; 124(Pt 13):2113-9. PubMed ID: 21628425
[TBL] [Abstract][Full Text] [Related]
3. Chk1-dependent S-M checkpoint delay in vertebrate cells is linked to maintenance of viable replication structures.
Zachos G; Rainey MD; Gillespie DA
Mol Cell Biol; 2005 Jan; 25(2):563-74. PubMed ID: 15632059
[TBL] [Abstract][Full Text] [Related]
4. Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe.
Niida H; Tsuge S; Katsuno Y; Konishi A; Takeda N; Nakanishi M
J Biol Chem; 2005 Nov; 280(47):39246-52. PubMed ID: 16159883
[TBL] [Abstract][Full Text] [Related]
5. Sterigmatocystin-induced checkpoint adaptation depends on Chk1 in immortalized human gastric epithelial cells in vitro.
Jiang X; Wang J; Xing L; Shen H; Lian W; Yi L; Zhang D; Yang H; Liu J; Zhang X
Arch Toxicol; 2017 Jan; 91(1):259-270. PubMed ID: 26914363
[TBL] [Abstract][Full Text] [Related]
6. Parvovirus-induced depletion of cyclin B1 prevents mitotic entry of infected cells.
Adeyemi RO; Pintel DJ
PLoS Pathog; 2014 Jan; 10(1):e1003891. PubMed ID: 24415942
[TBL] [Abstract][Full Text] [Related]
7. Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling.
Jurvansuu J; Fragkos M; Ingemarsdotter C; Beard P
J Mol Biol; 2007 Sep; 372(2):397-406. PubMed ID: 17663993
[TBL] [Abstract][Full Text] [Related]
8. Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase.
Müllers E; Silva Cascales H; Jaiswal H; Saurin AT; Lindqvist A
Cell Cycle; 2014; 13(17):2733-43. PubMed ID: 25486360
[TBL] [Abstract][Full Text] [Related]
9. Novel positive feedback loop between Cdk1 and Chk1 in the nucleus during G2/M transition.
Enomoto M; Goto H; Tomono Y; Kasahara K; Tsujimura K; Kiyono T; Inagaki M
J Biol Chem; 2009 Dec; 284(49):34223-30. PubMed ID: 19837665
[TBL] [Abstract][Full Text] [Related]
10. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
11. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
Sakurikar N; Thompson R; Montano R; Eastman A
Oncotarget; 2016 Jan; 7(2):1380-94. PubMed ID: 26595527
[TBL] [Abstract][Full Text] [Related]
12. Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells.
Nojima H; Homma H; Onozato Y; Kaida A; Harada H; Miura M
Exp Cell Res; 2020 Jan; 386(2):111720. PubMed ID: 31738907
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the G2/M transition by p53.
Taylor WR; Stark GR
Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
[TBL] [Abstract][Full Text] [Related]
14. DNA replication stress in CHK1-depleted tumour cells triggers premature (S-phase) mitosis through inappropriate activation of Aurora kinase B.
Zuazua-Villar P; Rodriguez R; Gagou ME; Eyers PA; Meuth M
Cell Death Dis; 2014 May; 5(5):e1253. PubMed ID: 24853431
[TBL] [Abstract][Full Text] [Related]
15. Lack of Casein Kinase 1 Delta Promotes Genomic Instability - The Accumulation of DNA Damage and Down-Regulation of Checkpoint Kinase 1.
Greer YE; Gao B; Yang Y; Nussenzweig A; Rubin JS
PLoS One; 2017; 12(1):e0170903. PubMed ID: 28125685
[TBL] [Abstract][Full Text] [Related]
16. Cdk-mediated phosphorylation of Chk1 is required for efficient activation and full checkpoint proficiency in response to DNA damage.
Xu N; Libertini S; Black EJ; Lao Y; Hegarat N; Walker M; Gillespie DA
Oncogene; 2012 Mar; 31(9):1086-94. PubMed ID: 21765472
[TBL] [Abstract][Full Text] [Related]
17. Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics.
Xiao Z; Xue J; Semizarov D; Sowin TJ; Rosenberg SH; Zhang H
Int J Cancer; 2005 Jul; 115(4):528-38. PubMed ID: 15688426
[TBL] [Abstract][Full Text] [Related]
18. Chk1, but not Chk2, is responsible for G2/M phase arrest induced by diallyl disulfide in human gastric cancer BGC823 cells.
Bo S; Hui H; Li W; Hui L; Hong X; Lin D; Dai WX; Wu YH; Ai XH; Hao J; Qi S
Food Chem Toxicol; 2014 Jun; 68():61-70. PubMed ID: 24650757
[TBL] [Abstract][Full Text] [Related]
19. Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitors.
Xiao Z; Xue J; Gu WZ; Bui M; Li G; Tao ZF; Lin NH; Sowin TJ; Zhang H
Biomarkers; 2008 Sep; 13(6):579-96. PubMed ID: 18671143
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
